These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 21397772)
21. The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation. Howard PA; Ellerbeck EF; Engelman KK; Patterson KL Pharmacoepidemiol Drug Saf; 2002; 11(7):569-76. PubMed ID: 12462133 [TBL] [Abstract][Full Text] [Related]
22. Ximelagatran in prevention of cardiovascular events. Molckovsky D; Boucher M Issues Emerg Health Technol; 2004 Nov; (62):1-4. PubMed ID: 15565751 [TBL] [Abstract][Full Text] [Related]
23. Predisposing preventable factors in patients with bleeding due to warfarin usage: Evaluation of 114 patients. Beyan E; Beyan C; Vaizoğlu SA Clin Appl Thromb Hemost; 2010 Dec; 16(6):684-7. PubMed ID: 19520686 [TBL] [Abstract][Full Text] [Related]
24. [Terbinafine and warfarin interaction]. Schmutz JL; Barbaud A; Tréchot P Ann Dermatol Venereol; 1999 May; 126(5):463. PubMed ID: 10434116 [No Abstract] [Full Text] [Related]
25. Pharmacogenomics and warfarin therapy. Ndegwa S Issues Emerg Health Technol; 2007 Oct; (104):1-8. PubMed ID: 17912794 [TBL] [Abstract][Full Text] [Related]
26. [Noscapine and warfarin--a potentially dangerous interaction]. Myhr K Tidsskr Nor Laegeforen; 2009 Mar; 129(6):540. PubMed ID: 19282895 [No Abstract] [Full Text] [Related]
27. Deadly drug interactions in emergency medicine. Prybys KM Emerg Med Clin North Am; 2004 Nov; 22(4):845-63. PubMed ID: 15474773 [TBL] [Abstract][Full Text] [Related]
28. Generic substitution: issues for problematic drugs. Henderson JD; Esham RH South Med J; 2001 Jan; 94(1):16-21. PubMed ID: 11213935 [TBL] [Abstract][Full Text] [Related]
29. Interaction between miconazole oral gel (Daktarin) and warfarin. Pillans P; Woods DJ N Z Med J; 1996 Sep; 109(1029):346. PubMed ID: 8862358 [No Abstract] [Full Text] [Related]
31. The Food and Drug Administration's role in promoting consistent labels for generic drugs. Duke JD; Kesselheim AS JAMA Intern Med; 2014 Aug; 174(8):1213-4. PubMed ID: 24957047 [No Abstract] [Full Text] [Related]
32. Canadian and US drug approval times and safety considerations. Rawson NS; Kaitin KI Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031 [TBL] [Abstract][Full Text] [Related]
33. Generic and alternative brand-name pharmaceutical equivalents: select with caution. Hendeles L; Hochhaus G; Kazerounian S Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793 [No Abstract] [Full Text] [Related]
34. Epistaxis associated with elevation of INR in a patient switched to generic warfarin--a comment. Murphy JE Pharmacotherapy; 2000 Jul; 20(7):863-5; discussion 869-71. PubMed ID: 10907981 [No Abstract] [Full Text] [Related]
35. Interaction of dicloxacillin with warfarin. Lacey CS Ann Pharmacother; 2004 May; 38(5):898. PubMed ID: 15054148 [No Abstract] [Full Text] [Related]